Once activated, NRF2 can promote carcinogenesis by facilitating several classical hallmarks of cancer, including angiogenesis, metabolic reprogramming, chronic proliferation, and resistance to cell death (36, 41, 56). The gene discussed is NFE2L2; the disease is cancer.